Optimization of Losartan potassium, Amlodipine besylate and
Formulation and Evaluation of Immediate Release Bilayer Tablets of Amlodipine Besylate and Losartan Potassium
152
SIMULTANEOUS ESTIMATION OF LOSARTAN POTASSIUM AND AMLODIPINE BESYLATE IN TABLET DOSAGE FORM BY UV SPECTROPHOTOMETER
5
STABILITY INDICATING HPTLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF AMLODIPINE BESYLATE AND LOSARTAN POTASSIUM AND CHARACTERISATION OF ACID DEGRADANT PRODUCT OF LOSARTAN
9
Development And Validation Of A Simple Isocratic Hplc-Uv Method For Simultaneous Determination Of Amlodipine Besylate And Losartan Potassium In Their Combined Tablet Dosage Forms
10
FORMULATION, EVALUATION AND OPTIMIZATION OF FLASH DISSOLVING ORAL FILM OF AMLODIPINE BESYLATE
15
FORMULATION, OPTIMIZATION AND EVALUATION OF CONTROLLED RELEASE MICROSPHERES OF LOSARTAN POTASSIUM
24
FORMULATION AND EVALUATION OF LOSARTAN POTASSIUM FLOATING TABLETS: OPTIMIZATION BY 23 FACTORIAL DESIGN
13
Validated RP HPLC method for the simultaneous determination of amlodipine besylate, and hydrochlorothiazide using losartan potassium as working standard in bulk and pharmaceutical formulation
12
Optimization of Transmucosal Buccal Delivery of Losartan Potassium using Factorial Design
8
Development and Optimization of Fast Dissolving Tablets of Losartan Potassium Using Natural Gum Mucilage
17
FORMULATION, OPTIMIZATION AND SIMULTANEOUS DETERMINATION OF ATORVASTATIN CALCIUM AND LOSARTAN POTASSIUM IN PURE AND BILAYER TABLETS
13
Preparation and Evaluation of Oral Dispersible Formulations of Amlodipine Besylate
14
FORMULATION AND EVALUATION OF BILAYER TABLETS OF TWO INCOMPATIBLE DRUGS AMLODIPINE BESILATE AND LOSARTAN POTASSIUM
7
Spectrophotometric and HPLC methods for simultaneous estimation of amlodipine besilate, losartan potassium and hydrochlorothiazide in tablets
5
Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study
8
FORMULATION AND EVALUATION OF AMLODIPINE BESYLATE OSMOTIC TABLETS
12
VISIBLE SPECTROSCOPIC METHOD FOR ESTIMATION OF AMLODIPINE BESYLATE IN TABLETS
5
RP HPLC method development and validation for simultaneous estimation of Losartan Potassium, Amlodipine Besilate and Hydrochlorthiazide in tablet dosage form
6
Olmesartan / Amlodipine Besylate / Hydrochlorothiazide
18
Norvasc V. (Amlodipine Besylate/Valsartan)
23